Vol. 4 No. 2 (2021): Volume 4, Issue 2

Articles

• Re-Profiling of US-FDA Approved Drugs for COVID-19 by In-silico Studies

  Akash Parab, Gaganjyot Kaur, Abhishek Sharma, Gursewak Bhuller, Sharvari Chitnis, Ankit Chindaliya, Mayur Weta

  50-73

  • PDF